[1]
Ravasio, R., Costanzo, A., Antonelli, S., Maiorino, A. and Losi, S. 2021. Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment. 8, 1 (Apr. 2021), 53–57. DOI:https://doi.org/10.33393/grhta.2021.2222.